KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Shares Outstanding (Diluted Average): 2020-2024

Historic Shares Outstanding (Diluted Average) for Medpace Holdings (MEDP) over the last 5 years, with Dec 2024 value amounting to $32.0 million.

  • Medpace Holdings' Shares Outstanding (Diluted Average) fell 7.41% to $29.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.7 million, marking a year-over-year decrease of 7.41%. This contributed to the annual value of $32.0 million for FY2024, which is 0.54% up from last year.
  • Medpace Holdings' Shares Outstanding (Diluted Average) amounted to $32.0 million in FY2024, which was up 0.54% from $31.8 million recorded in FY2023.
  • In the past 5 years, Medpace Holdings' Shares Outstanding (Diluted Average) registered a high of $37.7 million during FY2020, and its lowest value of $31.8 million during FY2023.
  • Moreover, its 3-year median value for Shares Outstanding (Diluted Average) was $32.0 million (2024), whereas its average is $32.5 million.
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first decreased by 10.68% in 2022, then grew by 0.54% in 2024.
  • Over the past 5 years, Medpace Holdings' Shares Outstanding (Diluted Average) (Yearly) stood at $37.7 million in 2020, then dropped by 0.03% to $37.7 million in 2021, then declined by 10.68% to $33.7 million in 2022, then decreased by 5.43% to $31.8 million in 2023, then increased by 0.54% to $32.0 million in 2024.